Regarding the influence of SMI change on DFS of patients who underwent NAC, although a similar trend was observed among luminal, HER2-enriched, and TN breast cancer in this study, further large-scale studies are required to determine the importance of SMI change in each subtype of breast cancer. Here, ERBB2 is linked to breast cancer.